Cargando…
Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor prognosis and rising incidence. Late detection and a particularly aggressive biology are the major challenges which determine therapeutic failure. In this review, we present the current status and the recent advances i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688256/ https://www.ncbi.nlm.nih.gov/pubmed/31395068 http://dx.doi.org/10.1186/s13014-019-1345-6 |
_version_ | 1783442849220526080 |
---|---|
author | Orth, Michael Metzger, Philipp Gerum, Sabine Mayerle, Julia Schneider, Günter Belka, Claus Schnurr, Maximilian Lauber, Kirsten |
author_facet | Orth, Michael Metzger, Philipp Gerum, Sabine Mayerle, Julia Schneider, Günter Belka, Claus Schnurr, Maximilian Lauber, Kirsten |
author_sort | Orth, Michael |
collection | PubMed |
description | Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor prognosis and rising incidence. Late detection and a particularly aggressive biology are the major challenges which determine therapeutic failure. In this review, we present the current status and the recent advances in PDAC treatment together with the biological and immunological hallmarks of this cancer entity. On this basis, we discuss new concepts combining distinct treatment modalities in order to improve therapeutic efficacy and clinical outcome – with a specific focus on protocols involving radio(chemo)therapeutic approaches. |
format | Online Article Text |
id | pubmed-6688256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66882562019-08-14 Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches Orth, Michael Metzger, Philipp Gerum, Sabine Mayerle, Julia Schneider, Günter Belka, Claus Schnurr, Maximilian Lauber, Kirsten Radiat Oncol Review Pancreatic ductal adenocarcinoma (PDAC) is a highly devastating disease with poor prognosis and rising incidence. Late detection and a particularly aggressive biology are the major challenges which determine therapeutic failure. In this review, we present the current status and the recent advances in PDAC treatment together with the biological and immunological hallmarks of this cancer entity. On this basis, we discuss new concepts combining distinct treatment modalities in order to improve therapeutic efficacy and clinical outcome – with a specific focus on protocols involving radio(chemo)therapeutic approaches. BioMed Central 2019-08-08 /pmc/articles/PMC6688256/ /pubmed/31395068 http://dx.doi.org/10.1186/s13014-019-1345-6 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Orth, Michael Metzger, Philipp Gerum, Sabine Mayerle, Julia Schneider, Günter Belka, Claus Schnurr, Maximilian Lauber, Kirsten Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title_full | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title_fullStr | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title_full_unstemmed | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title_short | Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
title_sort | pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688256/ https://www.ncbi.nlm.nih.gov/pubmed/31395068 http://dx.doi.org/10.1186/s13014-019-1345-6 |
work_keys_str_mv | AT orthmichael pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT metzgerphilipp pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT gerumsabine pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT mayerlejulia pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT schneidergunter pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT belkaclaus pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT schnurrmaximilian pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches AT lauberkirsten pancreaticductaladenocarcinomabiologicalhallmarkscurrentstatusandfutureperspectivesofcombinedmodalitytreatmentapproaches |